Inventor · disambiguated record
Herbert Struemper
Also filed as: STRUEMPER HERBERT · STRUEMPER HERBERT K
2 granted patents·9 pending applications·15 citations·filing 2002–2020
57Inventor score
Top patents by PatentIndex Score
11 records- 0168US6862561B2Method and apparatus for computer modeling a jointENTELOS INC·Filed 2002·Granted Mar 1, 2005·13 cites·46 claims
- 0258US2005158321A1Treatment of rheumatoid arthritis with galectin-3 antagonistsENTELOS INC·Filed 2004·Application pending·0 cites
- 0357US7472050B2Method and apparatus for computer modeling a jointENTELOS INC·Filed 2005·Granted Dec 30, 2008·2 cites·24 claims
- 0456US2008201122A1Method and Apparatus for Computer Modeling of an Adaptive Immune ResponseENTELOS INC·Filed 2007·Application pending·0 cites
- 0553US2008213786A1Treatment of rheumatoid arthritis with galectin-3 antagonistsENTELOS INC·Filed 2008·Application pending·0 cites
- 0650US2008118466A1Treatment of rheumatoid arthritis with soluble fas-ligand cross-linkersENTELOS INC·Filed 2007·Application pending·0 cites
- 0750US2003104475A1Method and apparatus for computer modeling of an adaptive immune responseFiled 2002·Application pending·0 cites
- 0849US2005159357A1Treatment of rheumatoid arthritis with soluble Fas-ligand cross-linkersENTELOS INC·Filed 2004·Application pending·0 cites
- 0941US2023220092A1Anti-Blys Antibody for Treating Proteinuric Kidney DiseaseGLAXSMITHKLINE INTELLECTUAL PROPERTY MAN LIMITED·Filed 2020·Application pending·0 cites
- 1039US2022098303A1Combination treatments for cancer comprising belantamab mafodotin and an anti ox40 antibody and uses and methods thereofGLAXOSMITHKLINE IP DEV LTD·Filed 2020·Application pending·0 cites
- 1132US2019023791A1Combination Treatments and Uses and Methods ThereofGLAXOSMITHKLINE IP DEV LTD·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Herbert Struemper files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →